Fast Facts
Our Rebates, Discounts and Fees in 2020
$29.4 billion – Rebates, discounts and fees provided in 2020 to payers and others in the health system – more than half the list price (53%) of our medicines.
Cost-Sharing Increases Affect Adherence
Doubling co-pays has been found to reduce patients’ adherence to prescribed medicines by 25%–45%.
Reducing Patient Out-of-Pocket Costs in Part D
Tying cost-sharing to net price would result in 47% of Medicare beneficiaries would see reduction in out-of-pocket spending
Growth Rate of the 340B Program
The 340B Drug Discount Program tripled in size between 2014 and 2019 to nearly $30 billion
Growth Rate of the 340B Program
In recent years the 340B program has expanded at double-digit rates